pubmed-article:18832880 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18832880 | lifeskim:mentions | umls-concept:C2362514 | lld:lifeskim |
pubmed-article:18832880 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
pubmed-article:18832880 | lifeskim:mentions | umls-concept:C1373111 | lld:lifeskim |
pubmed-article:18832880 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:18832880 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:18832880 | pubmed:dateCreated | 2008-10-3 | lld:pubmed |
pubmed-article:18832880 | pubmed:abstractText | Long-term studies of tolerance to perinatal exposure to antiretroviral nucleoside reverse transcriptase inhibitors are required, in view of the potential genotoxicity of some of these molecules. | lld:pubmed |
pubmed-article:18832880 | pubmed:language | eng | lld:pubmed |
pubmed-article:18832880 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18832880 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18832880 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18832880 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18832880 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18832880 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18832880 | pubmed:issn | 1473-5571 | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:TubianaRoland... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:BlancheStépha... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:DozFrançoisF | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:MandelbrotLau... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:ClavelJacquel... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:AndréNicolasN | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:LacourBrigitt... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:WarszawskiJos... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:BavouxFrançoi... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:LevineMartine... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:BellecStéphan... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:BenhammouValé... | lld:pubmed |
pubmed-article:18832880 | pubmed:author | pubmed-author:ANRS-Enquête... | lld:pubmed |
pubmed-article:18832880 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18832880 | pubmed:day | 18 | lld:pubmed |
pubmed-article:18832880 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:18832880 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18832880 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18832880 | pubmed:pagination | 2165-77 | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:meshHeading | pubmed-meshheading:18832880... | lld:pubmed |
pubmed-article:18832880 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18832880 | pubmed:articleTitle | Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. | lld:pubmed |
pubmed-article:18832880 | pubmed:affiliation | Inserm, U822, Le Kremlin-Bicêtre, France. | lld:pubmed |
pubmed-article:18832880 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18832880 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18832880 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18832880 | lld:pubmed |